К вопросу о сложности диагностики синдрома Гудпасчера
________________________________________________
Podzolkov V.I., Makhnach G.K., Ishina T.I., et al. Difficulties in Goodpasture's syndrome diagnosing. Therapeutic Archive. 2019; 91 (3): #–67. DOI: 10.26442/00403660.2019.03.000044
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
В статье приведены современные сведения об эпидемиологии, этиологии и патогенезе, принципах диагностики и лечения этого редкого заболевания, а также клиническое наблюдение пациента с синдромом Гудпасчера. Определены особенности течения болезни у данного больного.
Ключевые слова: анти-БМК-ассоциированная болезнь, синдром Гудпасчера, легочно-почечный синдром, прогрессирующий гломерулонефрит.
________________________________________________
The article analyzes the diagnosis and treatment of anti-GBM antibody disease (Goodpasture's syndrome) – a rare, severe progressive disease, associated with anti-glomerular basement membrane antibody-induced pulmonary hemorrhage and glomerulonephritis. The main problem of this pathology is late diagnosis, resulted in ineffective treatment. The article provides current information on the epidemiology, etiology and pathogenesis, diagnosis, and treatment of Goodpasture’s syndrome, as well as clinical case of a patient with this rare disease.
Keywords: anti-GBM antibody disease, Goodpasture's syndrome, pulmonary-renal syndrome, rapidly progressive glomerulonephritis.
2. Stanton MC, Tange JD. Goodpasture's syndrome (pulmonary haemorrhage associated with glomerulonephritis). Australasian annals of medicine. 1958;7(2):132-44.
3. Silvarino R, Noboa O, Cervera R. Anti-glomerular basement membrane antibodies. Israel Medical Association J. 2014;16(11):727-32.
4. Hellmark T, Segelmark M. Diagnosis and classification of Goodpasture's disease (anti-GBM). J Autoimmunity. 2014;48-49:108-12. https://doi.org/10.1016/j.jaut.2014.01.024
5. Yang R, Cui Z, Zhao J, Zhao MH. The role of HLA-DRB1 alleles on susceptibility of Chinese patients with anti-GBM disease. Clinical Immunology. 2009;133(2):245-50. https://doi.org/10.1016/j.clim. 2009.07.005
6. Meyera D, Colesb A, Oyuelac P, et al. Case report of anti-glomerular basement membrane disease following alemtuzumab treatment of relapsing–remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 2013;2(1):60-3. https://doi.org/10.1016/j.msard.2012.07. 002
7. Ohlsson S, Herlitz H, Lundberg S, et al. Circulating Anti-Glomerular Basement Membrane Antibodies With Predominance of Subclass IgG4 and False-Negative Immunoassay Test Results in Anti-Glomerular Basement Membrane Disease. Amer J Kidney Diseases. 2014;63:289-93. https://doi.org/10.1053/j.ajkd.2013.08.032
8. Cui Z, Zhao MH. Advances in human antiglomerular basement membrane disease. Nature Reviews Nephrology. 2011;7(12):697-705. https://doi.org/10.1038/nrneph.2011.89
9. Grecoa A, IdaRizzo M, DeVirgilio A, et al. Goodpasture's syndrome: A clinical update. Autoimmunity Reviews. 2015;14(3):246-53. https://doi.org/10.1016/j.autrev.2014.11.006
10. Feragalli B, Mantini C, Sperandeo M, Galluzzo M, Belcaro G, Tartaro A, et al. The lung in systemic vasculitis: radiological patterns and differential diagnosis. The British J Radiology. 2016;89:20150992. https://doi.org/10.1259/bjr.20150992
________________________________________________
1. Mukhin NA. Goodpasture`s syndrome: pathogenesis, diagnosis, treatment. Pharmateca. 2011;18:8-14 (In Russ.)
2. Stanton MC, Tange JD. Goodpasture's syndrome (pulmonary haemorrhage associated with glomerulonephritis). Australasian annals of medicine. 1958;7(2):132-44.
3. Silvarino R, Noboa O, Cervera R. Anti-glomerular basement membrane antibodies. Israel Medical Association J. 2014;16(11):727-32.
4. Hellmark T, Segelmark M. Diagnosis and classification of Goodpasture's disease (anti-GBM). J Autoimmunity. 2014;48-49:108-12. https://doi.org/10.1016/j.jaut.2014.01.024
5. Yang R, Cui Z, Zhao J, Zhao MH. The role of HLA-DRB1 alleles on susceptibility of Chinese patients with anti-GBM disease. Clinical Immunology. 2009;133(2):245-50. https://doi.org/10.1016/j.clim. 2009.07.005
6. Meyera D, Colesb A, Oyuelac P, et al. Case report of anti-glomerular basement membrane disease following alemtuzumab treatment of relapsing–remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 2013;2(1):60-3. https://doi.org/10.1016/j.msard.2012.07. 002
7. Ohlsson S, Herlitz H, Lundberg S, et al. Circulating Anti-Glomerular Basement Membrane Antibodies With Predominance of Subclass IgG4 and False-Negative Immunoassay Test Results in Anti-Glomerular Basement Membrane Disease. Amer J Kidney Diseases. 2014;63:289-93. https://doi.org/10.1053/j.ajkd.2013.08.032
8. Cui Z, Zhao MH. Advances in human antiglomerular basement membrane disease. Nature Reviews Nephrology. 2011;7(12):697-705. https://doi.org/10.1038/nrneph.2011.89
9. Grecoa A, IdaRizzo M, DeVirgilio A, et al. Goodpasture's syndrome: A clinical update. Autoimmunity Reviews. 2015;14(3):246-53. https://doi.org/10.1016/j.autrev.2014.11.006
10. Feragalli B, Mantini C, Sperandeo M, Galluzzo M, Belcaro G, Tartaro A, et al. The lung in systemic vasculitis: radiological patterns and differential diagnosis. The British J Radiology. 2016;89:20150992. https://doi.org/10.1259/bjr.20150992
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия
________________________________________________
V.I. Podzolkov, G.K. Makhnach, T.I. Ishina, A.B. Ponomarev, I.D. Medvedev
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia